Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis

Recruiting N/A Interventional Study
Sleep Apnea Syndromes
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
500 (estimated)
Sponsor
Mitral · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the effectiveness of the Apneal® app in diagnosing sleep apnea syndrome (SAS) in adults who require polysomnography (PSG) as part of routine care. The main questions it aims to answer are: * Can Apneal® accurately classify the SAS severity into four categories (normal: AHI \< 5, mild: 5 ≤ AHI \< 15, moderate: 15 ≤ AHI \< 30, and severe: AHI ≥ 30) com…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals, male or female, aged 18 years or older (no upper age limit). * Individuals for whom polysomnography (PSG) is indicated as part of routine care, regardless of the specific indication. * Individuals with a reported total sleep time of at least 6 hours, in accordance…
Contacts

Guillaume Cathelain, PhD

+33672448711

guillaume.cathelain@apneal.ai

CONTACT

Lola Martin

+33744475942

lola.martin@stane-groupe.fr

CONTACT